Metraipolis › archive › dc_fb67ae3e1540
Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA) — Europe PMC PMID:42374501
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42374501
- DOI
- 10.1186/s13195-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T15:11:56.927Z
- SHA-256 of the archived text
5dd7d50b8231356e97e1a23a59f544a7fbe54ee5fc921f254f4a804c1b3df0d2- Stable URL of this page
https://metraipolis.com/documento/dc_fb67ae3e1540
How to cite
Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA) — Europe PMC PMID:42374501 — Europe PMC (en), https://europepmc.org/article/MED/42374501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb67ae3e1540 (Metraipolis archive dc_fb67ae3e1540, sha256 5dd7d50b8231356e97e1a23a59f544a7fbe54ee5fc921f254f4a804c1b3df0d2)
BibTeX
@misc{dcfb67ae3e1540,
title = {Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA) — Europe PMC PMID:42374501},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42374501},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb67ae3e1540; sha256 5dd7d50b8231356e97e1a23a59f544a7fbe54ee5fc921f254f4a804c1b3df0d2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42374501. Agents can read the archived copy with the MCP tool read_document.